Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. / Lange, Peter; Celli, Bartolome; Agustí, Alvar; Jensen, Gorm Boje; Divo, Miguel; Faner, Rosa; Guerra, Stefano; Marott, Jacob Louis; Martinez, Fernando D; Martinez-Camblor, Pablo; Meek, Paula; Owen, Caroline A; Petersen, Hans; Pinto-Plata, Victor; Schnohr, Peter; Sood, Akshay; Soriano, Joan B; Tesfaigzi, Yohannes; Vestbo, Jørgen.
I: New England Journal of Medicine, Bind 373, Nr. 2, 09.07.2015, s. 111-122.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
AU - Lange, Peter
AU - Celli, Bartolome
AU - Agustí, Alvar
AU - Jensen, Gorm Boje
AU - Divo, Miguel
AU - Faner, Rosa
AU - Guerra, Stefano
AU - Marott, Jacob Louis
AU - Martinez, Fernando D
AU - Martinez-Camblor, Pablo
AU - Meek, Paula
AU - Owen, Caroline A
AU - Petersen, Hans
AU - Pinto-Plata, Victor
AU - Schnohr, Peter
AU - Sood, Akshay
AU - Soriano, Joan B
AU - Tesfaigzi, Yohannes
AU - Vestbo, Jørgen
PY - 2015/7/9
Y1 - 2015/7/9
N2 - BACKGROUND: Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms.METHODS: We stratified participants in three independent cohorts (the Framingham Offspring Cohort, the Copenhagen City Heart Study, and the Lovelace Smokers Cohort) according to lung function (FEV1 ≥80% or <80% of the predicted value) at cohort inception (mean age of patients, approximately 40 years) and the presence or absence of COPD at the last study visit. We then determined the rate of decline in FEV1 over time among the participants according to their FEV1 at cohort inception and COPD status at study end.RESULTS: Among 657 persons who had an FEV1 of less than 80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 years of observation, whereas among 2207 persons who had a baseline FEV1 of at least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 22 years of observation (P<0.001). Approximately half the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years of age and had a rapid decline in FEV1 thereafter, with a mean (±SD) decline of 53±21 ml per year. The remaining half had had a low FEV1 in early adulthood and a subsequent mean decline in FEV1 of 27±18 ml per year (P<0.001), despite similar smoking exposure.CONCLUSIONS: Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD. (Funded by an unrestricted grant from GlaxoSmithKline and others.).
AB - BACKGROUND: Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms.METHODS: We stratified participants in three independent cohorts (the Framingham Offspring Cohort, the Copenhagen City Heart Study, and the Lovelace Smokers Cohort) according to lung function (FEV1 ≥80% or <80% of the predicted value) at cohort inception (mean age of patients, approximately 40 years) and the presence or absence of COPD at the last study visit. We then determined the rate of decline in FEV1 over time among the participants according to their FEV1 at cohort inception and COPD status at study end.RESULTS: Among 657 persons who had an FEV1 of less than 80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 years of observation, whereas among 2207 persons who had a baseline FEV1 of at least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 22 years of observation (P<0.001). Approximately half the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years of age and had a rapid decline in FEV1 thereafter, with a mean (±SD) decline of 53±21 ml per year. The remaining half had had a low FEV1 in early adulthood and a subsequent mean decline in FEV1 of 27±18 ml per year (P<0.001), despite similar smoking exposure.CONCLUSIONS: Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD. (Funded by an unrestricted grant from GlaxoSmithKline and others.).
KW - Adult
KW - Aged
KW - Cohort Studies
KW - Disease Progression
KW - Female
KW - Forced Expiratory Volume
KW - Humans
KW - Male
KW - Middle Aged
KW - Pulmonary Disease, Chronic Obstructive
KW - Smoking
KW - Young Adult
U2 - 10.1056/NEJMoa1411532
DO - 10.1056/NEJMoa1411532
M3 - Journal article
C2 - 26154786
VL - 373
SP - 111
EP - 122
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 2
ER -
ID: 153788008